GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
78 hedge funds and large institutions have $402M invested in GenMark Diagnostics, Inc in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
–
Holders Change %
0%
% of All Funds
2.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
10
Increased
35
Reduced
21
Closed
8
Calls
$171K
Puts
–
Net Calls
+$171K
Net Calls Change
+$173K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$8.27M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.32M |
| 3 |
Millennium Management
New York
|
+$2.91M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.51M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$2.23M |
Top Sellers
| 1 |
PC
PointState Capital
New York
|
-$3.97M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.93M |
| 3 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$2.98M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$2.53M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$2.34M |
